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KAJIAN PENGGALAKKAN PERTUMBUHAN TULANG MENGGUNAKAN 
SEL STEM DARIPADA GIGI DESIDUS DAN SEL STEM BERSAMA 
KERANGKA BIPHASIC KALSIUM PHOSFAT DWIFASA DI DALAM 





Osteogenesis Regangan (OR) yang digambarkan sebagai kejuruteraan tisu tulang 
dalaman telah menjadi semakin popular di tahun-tahun kebelakangan ini dan teknik 
penggunaan telah mengalih perhatian kepada rangka kraniofasial yang telah 
mengembangkan bilangan rawatan alternatif untuk pesakit yang tidak normal dan 
kekurangan maksilofasial. Ia telah digunakan pertama kali dalam pembedahan ortopedik 
21 
untuk pembetulan kerencatan pertumbuhan anggota badan, dan seterusnya telah 
digunakan dalam rawatan microsomia kraniosfasial dan kecacatan tulang. Dalam OR, 
pembentukan tulang yang baru adalah didorong oleh pemisahan secara beransur-ansur 
segmen bertulang selepas osteotomi atau kortikotomi semasa proses biasa penyembuhan 
patah yang diganggu oleh penggunaan daya tarikan secara beransur-ansur terhadap kalus 
lembut. Walaupun OR mempunyai beberapa kelebihan yang nyata berbanding kaedah 
pembedahan tradisional terutamanya kedua-dua tisu yang lembut dan keras yang akan 
memanjang pada masa yang sama, namun kelemahan utama adalah rawatan yang lama 
yang kadangkala tidak dapat diterima oleh pesakit dan boleh dikaitkan dengan 
komplikasi bertulang dan tisu lembut dan kemungkinan  
 
penyatuan berserabut atau ketidaksatuan kekal sebagai batasan utama yang menghalang 
amalan klinikal yang selanjutnya. Banyak kajian telah memberi tumpuan kepada 
promosi pembentukan tulang baru untuk memendekkan siri gangguan 
osteogenesis. Cara fizikal telah dimasukkan ke medan elektromagnetik berdenyut, 
keamatan ultrabunyi rendah dan rangsangan elektrik. Kaedah intervensi seperti 
pemindahan daripada sel-sel  seperti osteoblast atau sumsum tulang ke bahagian 
gangguan, suntikan faktor pertumbuhan atau plasma platelet yang padat dan terapi gen 
juga telah digunakan untuk mempercepatkan kematangan tulang yang dihasilkan. 
Beberapa kaedah bukan intervensi, seperti penggunaan asid kalsitonin, alendronate dan 
zoledronik juga telah menampakkan kejayaan awal. Kejuruteraan tisu (KT) adalah satu 
bidang baru yang sangat menjanjikan rekonstruktif yang menarik dalam kemajuan 
terkini dalam bidang perubatan dan pembedahan. Tiga elemen utama KT adalah sel 
22 
stem, randuk dan faktor pertumbuhan. Sel stem dari gigi daun luruh exfoliatif (SHED) 
telah terbukti mampu dibezakan kepada osteoblas dan kondrosit-kondrosit dalam 
pembentukan tulang vitro dan in vivo dan menjadi sumber sel utama bagi kejuruteraan 
tisu tulang. Ia telah digunakan dalam pembinaan semula kecacatan saiz 
kritikal.Penggunaan SHED semasa gangguan osteogenesis untuk menggalakkan 
pertumbuhan tulang baru belum dilaporkan. Microporus dwifasa kalsium fosfat seramik 
(MDKF) merupakan biomaterial yang digunakan sebagai pengisi tulang dan sebagai 
tangga-tangga dalam kejuruteraan tisu tulang. Tujuan utama kajian ini adalah untuk 
menguji sama ada penambahan SHED dan komposit yang terdiri daripada pilihan dalam 
granul MDKF dalam osteotomy sebagai kejuruteraan tisu membina potensi peningkatan 
osteogenik dalam menjana semula OR. MBCP disintesiskan dengan ciri-ciri yang 
diingini, dicirikan dan diuji dalam cytotoxicity vitro. SHD adalah terpencil, berkembang 
dan dicirikan. Lapan belas arnab putih New Zealand telah dibahagikan kepada 3 
kumpulan. Kumpulan A merupakan kumpulan kawalan (tiada intervensi dalam potongan 
osteotomy), kumpulan B, 6 juta sel-sel (SHD) telah dipindahkan dan kumpulan C, (SHD 
/ BCP membina) telah dipindahkan ke dalam potongan osteotomy. Janaan semula itu 
dinilai dalam 3 tempoh; 2,4 dan 6 minggu secara postoperatif menggunakan X-ray 
konvensional, bahagian histologi dan ukuran histomorfometrik. Jumlah tulang yang baru 
ditentukan kuantitinya menggunakan penganalisis imej Hasilnya menunjukkan bahawa 
kedua-dua SHD dan SHD / MBCP membina meningkatkan pembentukan 
tulang. Peratusan tulang yang baru tumbuh pada 2 minggu kawalan, SHD dan SHD 
/MBCP adalah 18,41, 41,53 dan 57,28, pada minggu 4 31,68, 59,78 DAN 66,49 DAN 
DALAM MINGGU 6 52.34,60.24 dan 72,98%. Kesimpulannya, kajian ini boleh 
memberikan maklumat tambahan dan bukti daripada pelbagai mekanisme tindakan SHD 
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dalam pembentukan tulang yang mungkin berguna dalam memilih tulang yang berkesan 
menggalakkan binaan untuk pembentukan tulang. Seperti yang telah ditunjukkan, kedua-
dua SHD dan SHD / MBCP mempunyai aktiviti osteopromosi dan potensi binaan 
pembentukan tulang. Kajian lanjut tentang kesan SHD dan SHD / MBCP kekal penting 
kerana ia akan merentas laluan dalam membangunkan binaan osteopromotik untuk 
regangan osteopromosi manusia. MDKF disintesiskan dengan ciri-ciri yang diingini, 
diberi ciri-ciri dan diuji dalam cytotoxicity vitro. SHD adalah terpencil, berkembang dan 
diberi ciri-ciri. Lapan belas Neozeanald putih arnab telah dibahagikan kepada tiga 
kumpulan. Kumpulan A kawalan (campur tangan tidak digunakan dalam pemotongan 
osteotomy, kumpulan B, 6 juta sel-sel (SHD) telah dipindahkan dan kumpulan C, SHD / 
MBCP membina telah dipindahkan ke dalam potongan osteotomy.Penjanaan semula itu 
dinilai dalam 3 tempoh 2,4 dan 6 minggu secara post operatif menggunakan Xray 
konvensional, bahagian histologi dan ukuran histomorfometrik. Jumlah tulang yang baru 
dibilang menggunakan penganalisis imej. Hasilnya menunjukkan bahawa kedua-dua 
SHD dan SHD/ MBCP membantu meningkatkan pembentukan tulang. Peratusan tulang 
yang baru dibentuk pada 2 minggu kawalan, SHD l dan SHD / MBCP 18,41, 35.97 dan 
57,28, pada minggu 4 31,68, 59,78 dan 66,49 dan dalam minggu 6 52.34,60.24 dan 
72,98%. Kesimpulannya, kajian kami boleh memberikan maklumat tambahan dan bukti 
daripada pelbagai mekanisma tindakan SHD dalam pembentukan tulang yang mungkin 
berguna dalam memilih tulang yang berkesan menggalakkan pembinaan untuk 
pembentukan tulang. Seperti yang telah ditunjukkan kedua-dua SHD dan SHD / MBCP 
mempunyai aktiviti osteopromosi dan tulang yang berpotensi membentuk 
pembinaan.Kajian lanjut tentang kesan SHD kedua-dua SHD/ BCP kekal penting kerana 
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OSTEOPROMOTION OF MANDIBULAR DISTRACTION OSTEOGENESIS 
USING STEM CELLS FROM HUMAN DECIDUOUS TEETH AND IN 




Distraction osteogenesis (DO) is described as endogenous bone tissue engineering has 
become increasingly popular in recent years and the application of distraction technique 
to the craniofacial skeleton has expanded the number of treatment alternatives for 
patients with maxillofacial abnormalities and deficiencies. It is applied first in 
orthopedic surgery for correction of limb length discrepancies, and subsequently has 
been utilized in the treatment of craniofacial microsomia and bony defect. In DO, new 
bone formation is induced by gradual separation of bony segments after an osteotomy or 
corticotomy during which the normal process of fracture healing is interrupted by the 
application of gradual traction to the soft callus. DO has some distinct advantages over 
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traditional surgical methods which involve the elongation of both hard and soft tissue at 
the same time. The major disadvantage is the long treatment time which is some time 
not well tolerated by patients and the chance of associated bony and soft-tissue 
complications with possible fibrous union or nonunion remains as major limitations 
impeding its further clinical application. Many studies have focused on the promotion of 
new bone formation to shorten the course of DO. Physical means have included pulsed 
electromagnetic fields, low- intensity ultrasound and electrical stimulation, 
interventional methods such as transplantation of osteoblast-like cells or bone marrow to 
the distraction site.  Bone formation in vivo has become the main cell source for bone 
tissue engineering, it has been used in critical size defect reconstruction. The application 
of stem cells from exfoliative deciduous teeth (SHED) during distraction, injection of 
growth factors or platelet rich plasma and gene therapy have also been applied to 
accelerate the maturation of the regenerated bone. Some non interventional methods, 
such as administration of calcitonin, alendronate and zoledronic acid have also shown 
promising results. Tissue engineering (TE) is a new highly promising field of 
reconstruction that is drawing attention in recent advances in medicine and surgery. The 
main 3 element of TE are stem cells, scaffold and growth factor. SHED has been proven 
to be capable of differentiating into osteoblasts and chondrocytes in vitro. The usage of 
stem cells from human deciduous teeth (SHD) to promote new bone formation in DO 
has yet not been reported. Macroporous biphasic calcium phosphate ceramic (MBCP) is 
biomaterial used as bone filler and as a scaffold in bone tissue engineering. The main 
aim of this study was to test whether the addition of SHD and a composite consisting of 
SHD seeded in MBCP granules in osteotomy as a tissue engineering construct increases 
osteogenic potential in DO. MBCP was synthesized with desirable properties, Calicum / 
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Phosphate ratio, micro and macro porosities and particle size. The material was 
characterized using x ray diffraction, scanning electron microscope and particle size 
analyzer. In vitro cytotoxicity was performed to test the biocompatibility of the 
synthesized macroporous biphasic calcium phosphate. Stem cells were isolated from 
human pulp of deciduous teeth, expanded in vitro and characterized using 2 antibodies 
CD 166 and 105. The in vivo study was performed using rabbit’s model, Eighteen New 
Zealand white rabbits were divided into 3 groups. Group A underwent DO without 
addition of materials as control, group B had 6 million cells (SHD) transplanted in 
osteotomy gap and group C had SHD/BCP construct consisted of 6 million cells in 50 
mg MBCP transplantation. DO protocol was 4 days latency period, 6 days  
distraction period 1mm/day and assessed in 3 consolidation periods 3, 18 and 32 days. 
The regenerate was evaluated in 3 intervals of 2, 4 and 6 weeks postoperative periods, 
clinically, radiographically using conventional X ray, significance of callus formation, 
formation of bone cortex and bone marrow cavity were evaluated to compare between 
groups. Histological sections for new bone formation, blood vessels, cartilage and 
fibrous tissue were assessed. Quantitative histomorphometric measurements were 
carried out using Zeiss image analysis system to quantify the amount of bone formed, 
cartilage and fibrous tissue ruminants. The samples were also analyzed 
histomorphometrically for the grade of osseous regeneration using an established 
numerical scoring system for the assessment of bone healing. Serial sections were scored 
for 2 independent bone-forming indices stage of bone union and grade of bone maturity. 
The result demonstrated that MBCP synthesized with Ca/P ratio of 1.52 confirmed by 
XRD, micro and macro porosity of 200-400 µm was confirmed by SEM. In vitro 
cytotoxicty showed that MBCP is free of toxicity, Mann-Whitney test detected that the 
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optical absorbance (OD) median of SHD for all MBCP concentrations was statically 
higher than control using 7 days extraction, P value < 0.001 for each. SHD were 
successfully isolated by enzyme digestion method. Early cell cultures revealed typical 
fibroblast-like spindle shaped cells arranged in colonies. Results of flow cytometry 
showed expression of CD 105 and 166, >42 and >95% respectively. The in vivo study 
showed that both SHD and SHD/MBCP construct enhance bone formation in all time 
points 2, 4 and 6 weeks postoperatively. Radiographic examination revealed presence of 
radiological evidence of DO healing in all treatment groups with more bone formation in 
the transplanted one. Histologically, intramembrance ossification was evidence, the 
highest bony formation was seen in SHD/MBCP group followed by SHD group and the 
least amount was in control group. Histomorphometric measurement detected that the 
percentage of newly formed bone in 2 weeks control, SHD and SHD/BCP were 18.41, 
35.97 and 57.28% respectively, in week 4 were 31.68, 59.78 and 66.49% and in week 6 
were 52.34, 60.24 and 72.98% respectively. Non parametric ANOVA (Kruskal Whalis 
Test) showed significant difference between groups P value = 0.003. Bone-forming 
indices such as stage of bone union and grade of bone maturity were highest in 
SHD/BCP group and lowest in control group, Kruskal Whalis Test showed significant 
difference between groups P value = 0.001 and 0.002 respectively. In conclusion, this 
study may provide additional information and evidence of the various mechanisms of 
action of SHD in bone formation which may be useful in selecting effective bone 
promoting construct for bone formation. As we have shown both SHD and SHD/BCP 
have osteopromoting activities and potential bone forming construct. The 
osteopromoting effect is better with combination of SHD and BCP scaffold. Further 
studies on the effect of both SHD and SHD/BCP remain important as it may lead to 
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developing an osteopromotic construct for human distraction osteogenesis and to know 
whether SHD differentiate directly to form osteoblast or indirectly promote the bone 
formation in DO. 
 
 





Reconstruction of bone deficiency such as craniofacial anomalies and complex trauma 
can pose serious problems in clinical surgery, including orthopaedic, plastic/ 
reconstructive and craniofacial surgery. Successful bone repair depends on a sequential 
interaction of a tissue matrix scaffold with pluripotent cells and growth factors within 
the local environment. Only autogenous cancellous bone graft possesses all the 
important qualities of osteoinduction, osteoconduction, osteointegration and 
osteogenesis. Even though the healing of the autologous cancellous bone graft can be 
unpredictable, it is still considered the best material available to repair significant bone 
defects (Bauer and Muschler, 2000). Bone autograft is a graft of own cancellous bone 
tissue. However, the harvest of an autograft has several limitations, it requires a separate 
surgical approach with all its potential complications including prolonged surgery and 
anaesthetic time, donor site morbidity and pain, inadequate amount and quality of 
autograft (Ahlmann et al., 2002; Boone, 2003). 
